FTSE 100 stocks I’d buy after the US election results

FTSE 100’s sideways movement is underwhelming but not unsurprising as the US election results remain uncertain. However, there are some great individual stocks to buy now. 

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

There’s no clear winner in the US elections so far. Joe Biden is in the lead, but a win for the Democrats isn’t guaranteed. Unsurprisingly, stock markets are underwhelmed. The FTSE 100 index, for instance, has risen less than 1% so far today. I think the point to note here is that uncertain politics leads to uncertain markets. This has been amply clear to FTSE 100 investors since the Brexit vote. The point is underlined yet again now.

How I’d invest now

For me, this means that index investing is a no-go. I reckon the FTSE 100 won’t go anywhere in the days and months to come. I’d rather buy FTSE 100 stocks that are immune to political confusion or a weak economy. Clearly, this seems to be a consensus among the investing community today. Three of the top five FTSE 100 gainers today are healthcare provider AstraZeneca, pharmaceuticals company Hikma Pharmaceuticals, and e-grocer Ocado. 

FTSE 100 gainers

AstraZeneca has gained increased investor attention this year, since it began developing a Covid-19 vaccine. But even before that, it was a high-performing stock. Ideally, I’d wait for a dip before loading up on it, because its price has run up quite a bit. Similarly, Hikma Pharmaceuticals has signed an agreement with the US-based Gilead Sciences to manufacture its Covid-19 drug, Remdesivir. Compared to AstraZeneca, Hikma is affordable with an earnings ratio of less than 13 times, making it a good healthcare stock to buy.

Ocado’s share price increase to vertigo-inducing heights this year needs no introduction. As the convenience and safety of ordering supplies in catapulted demand for the online supermarket’s services to news highs, its share price followed suit. As the UK swings back into lockdown, Ocado will clearly continue to perform. Like AstraZeneca, its price may feel uncomfortably high too, but I don’t see it coming off meaningfully any time soon. Considering that there are no real FTSE 100 alternatives to the stock, I think now is a good time as any other to buy it. 

Indirect FTSE 100 beneficiaries

Apart from Ocado, online retailers in general have outperformed in 2020. Amazon is the most prominent example of this trend, but it’s not a UK-listed company. There are, however, FTSE 100 companies that have benefited from the online shopping trend. Consider paper packaging provider Smurfit Kappa. It’s also one of the biggest gainers today, following its trading update. It reported better than expected performance. 

There’s of course a possibility that as the recession makes a comeback, consumer spending will weaken enough to impact e-commerce sales. This, in turn, will impact the likes of Smurfit Kappa. However, if and how much the effect will be remains to be seen. I think this is another FTSE 100 stock to buy today. Alternatively, I’d consider its FTSE 100 peer DS Smith. Irrespective of the outcome of the US elections or any other political (non) triggers, I reckon these stocks will continue to be good buys. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Manika Premsingh owns shares of AstraZeneca and Ocado Group. The Motley Fool UK owns shares of and has recommended Amazon and Gilead Sciences. The Motley Fool UK has recommended DS Smith and Hikma Pharmaceuticals and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »